NanoViricides, Inc. (NNVC) stock
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
$1.16−0.08 (-6.45%)
Close on Nov 17, 2026Market cap $29.61MP/E –Yield –
NanoViricides operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NanoViricides's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.70M. For fiscal 2026 it was -$7.70M. The highest annual figure on record is -$2.05M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$7.70M | – |
| FY2025 | Jun 30, 2025 | -$8.48M | – |
| FY2024 | Jun 30, 2024 | -$6.32M | – |
| FY2023 | Jun 30, 2023 | -$5.67M | – |
| FY2022 | Jun 30, 2022 | -$5.89M | – |
| FY2021 | Jun 30, 2021 | -$8.21M | – |
| FY2020 | Jun 30, 2020 | -$6.67M | – |
| FY2019 | Jun 30, 2019 | -$6.80M | – |
| FY2018 | Jun 30, 2018 | -$7.78M | – |
| FY2017 | Jun 30, 2017 | -$7.90M | – |
| FY2016 | Jun 30, 2016 | -$6.83M | – |
| FY2015 | Jun 30, 2015 | -$6.21M | – |
| FY2014 | Jun 30, 2014 | -$6.33M | – |
| FY2013 | Jun 30, 2013 | -$5.80M | – |
| FY2012 | Jun 30, 2012 | -$4.22M | – |
| FY2011 | Jun 30, 2011 | -$4.51M | – |
| FY2010 | Jun 30, 2010 | -$2.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$2.12M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$1.93M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$2.05M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$1.59M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$1.70M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$1.99M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.19M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$2.59M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$1.48M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$1.94M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.72M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$1.17M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$1.50M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$1.74M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$1.40M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$1.03M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$1.40M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$1.66M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$2.11M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$724.23K | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$2.23M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$1.43M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$2.32M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$2.24M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$1.71M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$2.40M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$1.13M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$1.43M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$1.67M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$2.01M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$2.16M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$962.15K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$3.52M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$1.30M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$1.40M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$1.56M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$1.01M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$2.05M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$2.61M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$2.22M | – |
See a number that looks wrong?